Analyzing SeaStar Medical (ICU) and Its Rivals

SeaStar Medical (NASDAQ:ICU) is one of 232 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its rivals? We will compare SeaStar Medical to related companies based on the strength of its dividends, valuation, risk, institutional ownership, analyst recommendations, profitability and earnings.

Profitability

This table compares SeaStar Medical and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	N/A	N/A	-741.57%
SeaStar Medical Competitors	-740.00%	-98.42%	-28.15%

Earnings and Valuation

This table compares SeaStar Medical and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
SeaStar Medical	N/A	-$26.23 million	-0.39
SeaStar Medical Competitors	$1.04 billion	$4.11 million	1.67

SeaStar Medical’s rivals have higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 48.3% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 4.5% of SeaStar Medical shares are owned by insiders. Comparatively, 15.5% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

SeaStar Medical has a beta of -0.96, suggesting that its stock price is 196% less volatile than the S&P 500. Comparatively, SeaStar Medical’s rivals have a beta of 0.61, suggesting that their average stock price is 39% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for SeaStar Medical and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	0	0	0	0	N/A
SeaStar Medical Competitors	1610	4344	8521	226	2.50

As a group, “Surgical & medical instruments” companies have a potential upside of 24.36%. Given SeaStar Medical’s rivals higher possible upside, analysts clearly believe SeaStar Medical has less favorable growth aspects than its rivals.

Summary

SeaStar Medical rivals beat SeaStar Medical on 8 of the 10 factors compared.

SeaStar Medical Company Profile

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.